Head of Investor Relations
Beam Therapeutics Inc. (BEAM)Head of Investor Relations
Agios Pharmaceuticals, Inc. (AGIO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Holly Manning is recorded as Head of Investor Relations at Beam Therapeutics Inc. (BEAM) and Head of Investor Relations at Agios Pharmaceuticals, Inc. (AGIO). Holly Manning has spoken on 9 earnings calls across 2 companies, most recently for Beam Therapeutics Inc. on February 24, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Recorded roles and call appearances connecting this person to public companies.
Head of Investor Relations
Head of Investor Relations
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
